Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer

被引:29
作者
Tsolakidis, D. [1 ]
Amant, F. [1 ]
Van Gorp, T. [1 ]
Leunen, K. [1 ]
Neven, P. [1 ]
Vergote, I. [1 ]
机构
[1] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Obstet & Gynaecol, Div Gynaecol Oncol, B-3000 Louvain, European Union, Belgium
关键词
Primary debulking; Diaphragm; Coagulation; Stripping; Resection; Surgery; Ovarian cancer; Ovarian neoplasms; COMPLETE CYTOREDUCTIVE SURGERY; PRIMARY PERITONEAL CANCER; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; OPEN LAPAROSCOPY; FALLOPIAN-TUBE; CARCINOMA; RESECTION; SURVIVAL; IMPACT;
D O I
10.1016/j.ygyno.2009.07.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. The aim of this Study was to describe the role of diaphragmatic surgery in achieving optimal debulking in patients with advanced ovarian cancer and the assessment of the relative post-operative complications. Methods. Retrospective review was performed of medical records of 89 patients with epithelial ovarian cancer who underwent diaphragmatic surgery during their primary debulking surgery between September 1993 and December 2007. Four different approaches were performed: Coagulation (group I), stripping (group 2), combination stripping with coagulation (group 3) and diaphragm full thickness resection (group 4). Cytoreductive outcome, morbidity, overall Survival (OS) and disease-free Survival (DFS) were analysed. Results. Eight (8.9%) patients had FIGO stage IIIB, 64 (72%) stage IIIC and 17 (19.1%) stage IV disease. In 20 patients (22%) the diaphragmatic disease was coagulated, in 31 patients (35%) was only stripped, in 31 patients (35%) a combination of these techniques was applied and in 7 (8%) the disease was resected with the adjacent infiltrated part of the diaphragm muscle and the pleura above it. Debulking to no residual tumor was achieved in 90%, 86%. 86% and 100% for groups 1, 2, 3 and 4 respectively. Median DFS was 15,15,17 and overall Survival OS for groups 1, 2, and 3 was 40, 42, and 50 months respectively and was not yet reached for group 4. Minor and major complications were comparable among the groups. Pleural effusion was the most frequent associated complication and chest tube placement (17%) or thoracocentesis (12%) was necessary for the relief of respiratory distress. The perioperative mortality rate was 0%. The majority of cases were treated in the last five years Of our 15-year experience. Conclusions. Diaphragmatic surgery increases the rates of optimal primary debulking surgery and improves Survival with an acceptable and manageable morbidity rate. In patients with thick (>0.3 cm) OF large (>4 cm) lesions stripping the diaphragm or full thickness resection of the diaphragmatic muscle is preferred. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 50 条
  • [31] Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis
    Caruso, Giuseppe
    Palaia, Innocenza
    Bogani, Giorgio
    Tomao, Federica
    Perniola, Giorgia
    Panici, Pierluigi Benedetti
    Muzii, Ludovico
    Di Donato, Violante
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 33 (05)
  • [32] Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center
    Mueller, Jennifer J.
    Zhou, Qin C.
    Iasonos, Alexia
    O'Cearbhaill, Roisin E.
    Alvi, Farah A.
    El Haraki, Amr
    Eriksson, Ane Gerda Zahl
    Gardner, Ginger J.
    Sonoda, Yukio
    Levine, Douglas A.
    Aghajanian, Carol
    Chi, Dennis S.
    Abu-Rustum, Nadeem R.
    Zivanovic, Oliver
    GYNECOLOGIC ONCOLOGY, 2016, 140 (03) : 436 - 442
  • [33] Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis
    Ghirardi, V
    Moruzzi, M. C.
    Bizzarri, N.
    Vargiu, V.
    D'Indinosante, M.
    Garganese, G.
    Pasciuto, T.
    Loverro, M.
    Scambia, G.
    Fagotti, A.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (01) : 209 - 213
  • [34] Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma
    Seward, Shelly M.
    Winer, Ira
    CANCER AND METASTASIS REVIEWS, 2015, 34 (01) : 5 - 10
  • [35] Appropriate Recommendations for Surgical Debulking in Stage IV Ovarian Cancer
    Chern, Jing-Yi
    Curtin, John P.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (01) : 1 - 10
  • [36] Survival in stage IV ovarian cancer with increased use of debulking surgery and bevacizumab
    Verleye, Leen
    Castanares-Zapatero, Diego
    Devos, Carl
    De Gendt, Cindy
    Silversmit, Geert
    Van Damme, Nancy
    Hulstaert, Frank
    Thiry, Nancy
    Neyt, Mattias
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (04) : 543 - 548
  • [37] Feasibility of laparoscopic Visceral-Peritoneal Debulking (L-VPD) in patients with stage III-IV ovarian cancer: the ULTRA-LAP trial pilot study
    Tozzi, Roberto
    Noventa, Marco
    Saccardi, Carlo
    Spagnol, Giulia
    De Tommasi, Orazio
    Coldebella, Davide
    Marchetti, Matteo
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (02)
  • [38] Surgical Risk Score Predicts Suboptimal Debulking or a Major Perioperative Complication in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Stashwick, Caitlin
    Post, Miriam D.
    Arruda, Jaime S.
    Spillman, Monique A.
    Behbakht, Kian
    Davidson, Susan A.
    Kelly, Michael Greg
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (08) : 1422 - 1427
  • [39] Barriers to Primary Debulking Surgery for Advanced Ovarian Cancer in Latin America
    Paulino, Eduardo
    Rodrigues, Angelica Nogueira
    Strasser-Weippl, Kathrin
    St Louis, Jessica
    Bukowski, Alexandra
    Goss, Paul E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (08) : 1645 - 1649
  • [40] Primary versus interval debulking surgery in the management of ovarian cancer patients, current data summary
    Psomiadou, Victoria
    Fotiou, Alexandros
    Iavazzo, Christos
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (04)